BRPI0814231A2 - Derivados de pleuromutilina e seu uso como antimicrobianos - Google Patents

Derivados de pleuromutilina e seu uso como antimicrobianos

Info

Publication number: BRPI0814231A2
Authority: BR; Brazil
Prior art keywords: antimicrobians; pleuromutilin derivatives; pleuromutilin; derivatives
Prior art date: 2007-07-13

Application number

BRPI0814231-9A2A

Other languages

English (en)

Inventor

Klaus Thirring

Werner Heilmayer

Original Assignee

Nabriva Therapeutics Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-13

Filing date

2008-07-11

Publication date

2015-01-06

2008-07-11 Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag

2015-01-06 Publication of BRPI0814231A2 publication Critical patent/BRPI0814231A2/pt

2019-02-05 Publication of BRPI0814231B1 publication Critical patent/BRPI0814231B1/pt

2021-05-25 Publication of BRPI0814231B8 publication Critical patent/BRPI0814231B8/pt

Links

ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical class C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Crystallography & Structural Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)
Indole Compounds (AREA)

BRPI0814231A 2007-07-13 2008-07-11 derivados de pleuromutilina, seu uso e composição farmacêutica BRPI0814231B8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07450124A EP2014645A1 (en)	2007-07-13	2007-07-13	Pleuromutilin derivatives and their use as antimicrobials
PCT/AT2008/000254 WO2009009812A1 (en)	2007-07-13	2008-07-11	Pleuromutilin derivatives and their use as antimicrobials

Publications (3)

Publication Number	Publication Date
BRPI0814231A2 true BRPI0814231A2 (pt)	2015-01-06
BRPI0814231B1 BRPI0814231B1 (pt)	2019-02-05
BRPI0814231B8 BRPI0814231B8 (pt)	2021-05-25

Family

ID=38926421

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814231A BRPI0814231B8 (pt)	2007-07-13	2008-07-11	derivados de pleuromutilina, seu uso e composição farmacêutica

Country Status (12)

Country	Link
US (1)	US8173685B2 (pt)
EP (2)	EP2014645A1 (pt)
JP (1)	JP5613562B2 (pt)
KR (1)	KR101547543B1 (pt)
CN (1)	CN101801923B (pt)
BR (1)	BRPI0814231B8 (pt)
CA (1)	CA2693015C (pt)
EA (1)	EA019806B1 (pt)
HK (1)	HK1139127A1 (pt)
IL (1)	IL202947A (pt)
TW (1)	TWI423796B (pt)
WO (1)	WO2009009812A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2399904A1 (en) *	2010-05-26	2011-12-28	Nabriva Therapeutics AG	Process for the preparation of pleuromutilins
CN102180809B (zh) *	2011-03-08	2013-12-11	武汉工程大学	截短侧耳素的水杨酰胺醚化合物及其制备方法
CN103450057A (zh) *	2012-05-29	2013-12-18	大英九合生物化工股份有限公司	一种合成对甲苯磺酸截短侧耳素酯的方法
CN104803911B (zh) *	2014-01-23	2018-01-05	中国科学院上海药物研究所	一类截短侧耳素化合物、其药物组合物、合成方法与用途
CN103910663B (zh) *	2014-03-31	2016-06-29	华南农业大学	一种具有抗菌活性的截短侧耳素衍生物及其制备和应用
CN103910664B (zh) *	2014-03-31	2016-07-13	广东温氏大华农生物科技有限公司	一种抗菌活性截短侧耳素-磺胺衍生物及其制备方法和应用
CN113321672A (zh) *	2016-03-02	2021-08-31	比尔及梅琳达盖茨基金会	含硼小分子
WO2018144717A1 (en) *	2017-02-01	2018-08-09	Yale University	New pleuromutilin antibiotic compounds, compositions and methods of use and synthesis
TWI762573B (zh)	2017-02-10	2022-05-01	奧地利商納畢瓦治療有限責任公司	截短側耳素之純化
CN107417586A (zh) *	2017-06-21	2017-12-01	华南农业大学	一种截短侧耳素类抗生素及其制备方法和应用
US20230218558A1 (en) *	2020-04-17	2023-07-13	Nabriva Therapeutics GmbH	Novel therapeutic use of pleuromutilins
US11117859B1 (en) *	2021-02-12	2021-09-14	Shaanxi University Of Science And Technology	Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same
CN115850137B (zh) *	2022-11-12	2024-04-12	中国农业科学院兰州畜牧与兽药研究所	一种截短侧耳素衍生化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4060542A (en) *	1969-07-25	1977-11-29	Biochemie Gesellschaft M.B.H.	14-Desoxy-14 thiocyanato-acetoxy-mutilin
AT301753B (de) *	1969-07-25	1972-09-25	Biochemie Gmbh	Verfahren zur Herstellung neuer Pleuromutilin-Derivate
GB9614017D0 (en) *	1996-07-04	1996-09-04	Biochemie Gmbh	Organic compounds
WO2000027790A1 (en) *	1998-11-11	2000-05-18	Smithkline Beecham P.L.C.	Mutilin compounds
GB9918037D0 (en) *	1999-07-30	1999-09-29	Biochemie Gmbh	Organic compounds
GB0207495D0 (en) *	2002-03-28	2002-05-08	Biochemie Gmbh	Organic compounds
GB0209262D0 (en) *	2002-04-23	2002-06-05	Biochemie Gmbh	Organic compounds
GB0308114D0 (en) *	2003-04-08	2003-05-14	Glaxo Group Ltd	Novel compounds
GB0513058D0 (en) *	2005-06-27	2005-08-03	Sandoz Ag	Organic compounds

2007
- 2007-07-13 EP EP07450124A patent/EP2014645A1/en not_active Withdrawn
2008
- 2008-07-11 TW TW097126507A patent/TWI423796B/zh active
- 2008-07-11 JP JP2010515316A patent/JP5613562B2/ja not_active Expired - Fee Related
- 2008-07-11 EA EA201070138A patent/EA019806B1/ru not_active IP Right Cessation
- 2008-07-11 BR BRPI0814231A patent/BRPI0814231B8/pt not_active IP Right Cessation
- 2008-07-11 US US12/668,769 patent/US8173685B2/en active Active
- 2008-07-11 WO PCT/AT2008/000254 patent/WO2009009812A1/en active Application Filing
- 2008-07-11 CN CN200880107284.7A patent/CN101801923B/zh active Active
- 2008-07-11 KR KR1020107003165A patent/KR101547543B1/ko active IP Right Grant
- 2008-07-11 CA CA2693015A patent/CA2693015C/en active Active
- 2008-07-11 EP EP08772583.4A patent/EP2173707B1/en active Active
2009
- 2009-12-24 IL IL202947A patent/IL202947A/en active IP Right Grant
2010
- 2010-05-27 HK HK10105202.1A patent/HK1139127A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP5613562B2 (ja)	2014-10-22
CA2693015C (en)	2016-10-18
EA201070138A1 (ru)	2010-08-30
CN101801923B (zh)	2014-08-20
TWI423796B (zh)	2014-01-21
EP2014645A1 (en)	2009-01-14
EP2173707B1 (en)	2013-12-25
IL202947A (en)	2015-01-29
EA019806B1 (ru)	2014-06-30
WO2009009812A1 (en)	2009-01-22
CA2693015A1 (en)	2009-01-22
KR20100034764A (ko)	2010-04-01
BRPI0814231B1 (pt)	2019-02-05
CN101801923A (zh)	2010-08-11
EP2173707A1 (en)	2010-04-14
TW200920345A (en)	2009-05-16
US20100197734A1 (en)	2010-08-05
US8173685B2 (en)	2012-05-08
HK1139127A1 (en)	2010-09-10
KR101547543B1 (ko)	2015-08-26
JP2010533131A (ja)	2010-10-21
BRPI0814231B8 (pt)	2021-05-25

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-05-08	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-06-19	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2018-12-18	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-02-05	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/02/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/02/2019, OBSERVADAS AS CONDICOES LEGAIS
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/07/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-05-07	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.

Publication	Publication Date	Title
BRPI0814231A2 (pt)	2015-01-06	Derivados de pleuromutilina e seu uso como antimicrobianos
BRPI0920448A2 (pt)	2018-10-23	compostos spiro-oxindol e seu uso como agentes terapêuticos
BRPI0913885A8 (pt)	2016-08-02	tiadiazoliloxifenilamidinas e seu uso como fungicidas
BRPI0914536A2 (pt)	2016-07-26	tiadiazoliloxifenilamidinas e o uso destas como fungicidas
BRPI0815349A2 (pt)	2015-02-10	6-amino-5-cloro-4-pirimidinacarboxilatos substituídos com 2-(2-fluorofeni-la) e seu uso como herbicidas
BRPI1010533A2 (pt)	2016-03-15	tetrahidroazolopirazinas sulfoniladas e seu uso como medicamentos
BRPI1012533A2 (pt)	2015-09-22	composto de piradazinona e uso do mesmo
BR112012001061A2 (pt)	2016-03-29	glicosídeos 2,3-fluorados como inibidores de neuraminidase e seu uso como antivirais
BRPI1015145A2 (pt)	2018-01-30	derivados de tiazol e seu uso como receptores antagonistas de p2y12
BRPI0908225A2 (pt)	2016-11-01	derivados de piridazina e seu uso como agentes terapêuticos
BRPI0810679A2 (pt)	2014-10-07	Derivados de 4-aza indol e seu uso como fungicidas
BR112012008044A2 (pt)	2019-09-24	pteridinas e seu uso como agroquímicos
BRPI1004349A2 (pt)	2018-02-06	conjunto de rótulo e uso do mesmo
BRPI1010024A2 (pt)	2019-09-24	derivados de aminopirrolidinona e uso dos mesmos
CR20130360A (es)	2013-09-03	Compuesto heterocíclico y su uso
BRPI0914595A2 (pt)	2015-12-15	material substituto de madeira e seu uso
BRPI0816372A2 (pt)	2015-02-24	Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI1008082A2 (pt)	2015-08-25	Isotiazoliloxifenilamisinas e seu emprego como fungicidas
BRPI0810882A2 (pt)	2014-10-29	Derivados de ftalazinona e seu uso como medicamento para tratar câncer
BRPI1010621A2 (pt)	2016-06-21	derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI1007494A2 (pt)	2016-02-16	composto e uso do mesmo
BRPI0813263A2 (pt)	2014-12-30	Oxazolidinonas substituídas e seu uso
BRPI0808846A2 (pt)	2019-09-24	fenoxifenilamidinas 3-substituídas e seu uso como fungicidas
BRPI0810654A2 (pt)	2014-11-04	Tiadiazoliloxifenilamidinas e o seu uso como fungicidas.
BRPI0817061A2 (pt)	2015-03-24	Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3